A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson JS, Suskind DL, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen BL, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H; DINE-CD Study Group.
Lewis JD, et al.
Gastroenterology. 2021 Sep;161(3):837-852.e9. doi: 10.1053/j.gastro.2021.05.047. Epub 2021 May 27.
Gastroenterology. 2021.
PMID: 34052278
Free PMC article.
Clinical Trial.
Key secondary outcomes at week 6 included fecal calprotectin (FC) response (FC <250 mug/g and reduction by >50% among those with baseline FC >250 mug/g) and C-reactive protein (CRP) response (high-sensitivity CRP <5 mg/L and >50% reduction from baseline amon …
Key secondary outcomes at week 6 included fecal calprotectin (FC) response (FC <250 mug/g and reduction by >50% among those with basel …